Same-session KERARINGS and CXL procedure is effective

Article

Combined use of intracorneal ring segments (KERARINGS) and corneal collagen cross-linking (CXL) in a single session is more effective than performing the procedure in two sessions

A recent study, published in the British Journal of Ophthalmology, has proved that the combined use of intracorneal ring segments (KERARINGS) and corneal collagen cross-linking (CXL) in a single session is more effective than performing the procedure in two sessions.

Professor Tamer M El-Raggal, Magrabi Eye Hospital, Cairo, Egypt, conducted the prospective, comparative study in 16 eyes of 10 patients with progressive mild to moderate keratoconus.

The patients were randomly split into two groups. In the first group, 9 eyes underwent KERARINGS insertion, then CXL 6 months later. The second group involved seven eyes that received both procedures on the same day. A femtosecond laser (Intralase FS 60) was used for channel creation.

Both groups saw a significant improvement in uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA). But same day combination treatment group experienced a more statistically significant decrease in keratometric values.

It was found that both KERARINGS and CXL can be carried out safely in one or two sessions. However, the single-session procedure proved more efficient and successful in improving the corneal shape.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.